Dr. Ilana Cass, MD

Dr. Cass practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Cass' NPI, 1871576199, was assigned on November 21, 2005. Dr. Cass graduated from Icahn School Of Medicine At Mount Sinai in 1991. Dr. Cass holds New Hampshire license 19786.

Dr. Cass' primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Cass' primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Cass is also affiliated with Cheshire Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Cass to 2 more medical groups, each named with a free account. Dr. Cass' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cass practices, 2 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Cass' primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Cass is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Cass' licenses on file in 4 states: New Hampshire, Vermont, California and Florida.

Dmand AI lists hysterectomy among the conditions Dr. Cass treats.

CMS data shows 346 Medicare services from Dr. Cass across 9 procedure codes in 2024, for 145 Medicare patients. Medicare paid $47,533 for them.

CMS counts 145 Medicare patients who saw Dr. Cass in 2024. The largest group is 65 to 74, with 76 patients. 66% of them have high blood pressure, and 57% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cass' median patient age at 58, with 80% women.

In 2024, Dr. Cass wrote 227 Medicare Part D claims for 64 patients. 81% of them were for generic drugs. CMS names the drug for 145 of them, across 8 drugs with 11 or more claims each, at $279,542 in total drug cost. In 2023, CMS named 72 claims across 5 drugs.

Dr. Cass accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cass as offering telehealth. CMS counts 19 procedures of removal of the uterus by Dr. Cass, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 32 papers to Dr. Cass, published from 2007 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Ovarian Neoplasms, Chemotherapy, Adjuvant and Cystadenocarcinoma, Serous. Dr. Cass has published most often in Gynecol Oncol. Dr. Cass' most frequent co-authors are Beth Y. Karlan, MD, Joshua Garrett Cohen, MD and Andrew John Li, MD.

Dmand AI links Dr. Cass to 5 clinical trials, 3 of them phase 3 studies. Conditions studied include Brenner Tumor, Fallopian Tube Diseases and Neurotoxicity Syndromes. Gynecologic Oncology Group sponsors the most, 3.

CMS Open Payments shows 8 general payments to Dr. Cass from 6 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 86% of the total. GlaxoSmithKline, LLC. paid the most, $5,428.

Dmand AI lists 3 awards for Dr. Cass, most recently Top Doctors:LA Area in 2013.

Dr. Cass graduated from Icahn School Of Medicine At Mount Sinai in 1991. Dr. Cass is a member of American College of Obstetricians and Gynecologists.

Dr. Cass is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.